Nektar Therapeutics (NASDAQ:NKTR)

18.86
Delayed Data
As of May 13
 +0.29 / +1.56%
Today’s Change
15.40
Today|||52-Week Range
26.75
+10.94%
Year-to-Date

Today’s Trading

Previous close18.57
Today’s open19.33
Day’s range18.36 - 18.99
Volume44,739
Average volume (3 months)1,178,061
Market cap$3.7B
Data as of 4:00pm ET, 05/13/2021

Growth & Valuation

Earnings growth (last year)+1.17%
Earnings growth (this year)-20.88%
Earnings growth (next 5 years)-28.00%
Revenue growth (last year)+33.41%
P/E ratioNM
Price/Sales19.85
Price/Book3.36

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.08-0.14%
ALLOAllogene Therapeutic...-1.00-3.58%
ARVNArvinas Inc+0.69+1.10%
IOVAIovance Biotherapeut...-1.06-4.06%
Data as of 4:00pm ET, 05/13/2021

Financials

Next reporting dateAugust 12, 2021
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$152.9M
Annual profit (last year)-$444.4M
Net profit margin-290.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Francisco, California

Forecasts